Jon M. Plexico
Stonepine Capital Management, Llc
Assets Managed
$249.722M
Holdings
72
Last Quarter
2026 - Q1
Filed Date
20d ago
Growth Rate
82.32%(2Q avg: 46.84%)
Sustained Growth
3 quarters
Portfolio positions
This chart displays the top 10 holdings in Stonepine Capital Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 72 positions.
Assets under management
The assets under management (AUM) of Stonepine Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 249.722M in assets, with a quarterly growth rate of 82.32% and a 2-quarter average growth rate of 46.84%. The portfolio is managed by Jon M. Plexico, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
XBI Spdr S&p Biotech Etf
| 40.92% | $102.184M↓ Put 800,000 shares@ $127.73 avg price | New Position |
VSTM Verastem Inc
| 7.01% | $17.502M 3.302M shares@ $5.3 avg price | Increased 20.88% |
ADMA Adma Biologics Inc
| 6.82% | $17.029M 1.89M shares@ $9.01 avg price | Increased 155.41% |
TENX Tenax Therapeutics Inc
| 6.25% | $15.593M 975,200 shares@ $15.99 avg price | Increased 8106% |
EOLS Evolus Inc
| 3.59% | $8.956M 2.179M shares@ $4.11 avg price | Increased 33.56% |
CAMP Camp4 Therapeutics Corp
| 2.46% | $6.128M 1.39M shares@ $4.41 avg price | Increased 507.11% |
NKTR Nektar Therapeutics
| 2.45% | $6.116M 85,000 shares@ $71.95 avg price | Decreased -37.03% |
TERN Terns Pharmaceuticals Inc
| 2.12% | $5.272M↑ Call 100,000 shares@ $52.72 avg price | New Position |
ZVRA Zevra Therapeutics Inc
| 1.8% | $4.474M 480,000 shares@ $9.32 avg price | Decreased -15.65% |
ABEO Abeona Therapeutics Inc
| 1.52% | $3.793M 846,587 shares@ $4.49 avg price | Decreased -6.91% |
1-10 of 72